279 related articles for article (PubMed ID: 33959012)
21. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 4-aminophenylacetamide derivatives as intestine-specific farnesoid X receptor antagonists for the potential treatment of nonalcoholic steatohepatitis.
Chen C; Zhang B; Tu J; Peng Y; Zhou Y; Yang X; Yu Q; Tan X
Eur J Med Chem; 2024 Jan; 264():115992. PubMed ID: 38043493
[TBL] [Abstract][Full Text] [Related]
23. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
[TBL] [Abstract][Full Text] [Related]
24. Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.
Li J; Song J; Yan B; Weiss HL; Weiss LT; Gao T; Evers BM
FASEB J; 2021 May; 35(5):e21371. PubMed ID: 33811694
[TBL] [Abstract][Full Text] [Related]
25. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression.
Zhao LY; Xu JY; Shi Z; Englert NA; Zhang SY
Biochem Pharmacol; 2017 Oct; 142():194-203. PubMed ID: 28756207
[TBL] [Abstract][Full Text] [Related]
26. Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease.
Xu S; Kong L; Li L; Wang C; Gu J; Luo H; Meng Q
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166930. PubMed ID: 37918680
[TBL] [Abstract][Full Text] [Related]
27. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
28. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
[TBL] [Abstract][Full Text] [Related]
29. Ganoderma lucidum polysaccharide ameliorates cholesterol gallstone formation by modulating cholesterol and bile acid metabolism in an FXR-dependent manner.
Huang D; Shen S; Zhuang Q; Ye X; Qian Y; Dong Z; Wan X
Chin Med; 2024 Jan; 19(1):16. PubMed ID: 38268006
[TBL] [Abstract][Full Text] [Related]
30. The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.
Xiang D; Yang J; Liu L; Yu H; Gong X; Liu D
Biomed Pharmacother; 2023 Dec; 168():115606. PubMed ID: 37812893
[TBL] [Abstract][Full Text] [Related]
31. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
33. Ilexsaponin A
Zhao WW; Xiao M; Wu X; Li XW; Li XX; Zhao T; Yu L; Chen XQ
Front Pharmacol; 2021; 12():771976. PubMed ID: 34970143
[TBL] [Abstract][Full Text] [Related]
34. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.
Deng W; Fan W; Tang T; Wan H; Zhao S; Tan Y; Oware KA; Tan J; Li J; Qu S
Oxid Med Cell Longev; 2022; 2022():3589525. PubMed ID: 35251469
[TBL] [Abstract][Full Text] [Related]
35. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR.
Li L; Xu S; Wang W; Li X; Wang H; Yang Q; Wang C; Gu J; Luo H; Meng Q
Phytomedicine; 2024 May; 130():155693. PubMed ID: 38763006
[TBL] [Abstract][Full Text] [Related]
36. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.
Prawitt J; Abdelkarim M; Stroeve JH; Popescu I; Duez H; Velagapudi VR; Dumont J; Bouchaert E; van Dijk TH; Lucas A; Dorchies E; Daoudi M; Lestavel S; Gonzalez FJ; Oresic M; Cariou B; Kuipers F; Caron S; Staels B
Diabetes; 2011 Jul; 60(7):1861-71. PubMed ID: 21593203
[TBL] [Abstract][Full Text] [Related]
37. A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice.
Saraswathi V; Perriotte-Olson C; Ganesan M; Desouza CV; Alnouti Y; Duryee MJ; Thiele GM; Nordgren TM; Clemens DL
J Nutr Biochem; 2017 Apr; 42():149-159. PubMed ID: 28187366
[TBL] [Abstract][Full Text] [Related]
38. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
39. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
Li G; L Guo G
Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
[TBL] [Abstract][Full Text] [Related]
40. Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Nutr Metab (Lond); 2020; 17():34. PubMed ID: 32377219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
